Page 3 of 10

PY8.1-7 | Endocrine Physiology — Part 2

Hypothyroidism vs. Hyperthyroidism: Physiological Basis of Clinical Features

Hypothyroidism vs Hyperthyroidism

System Hypothyroidism (Decreased TH) Hyperthyroidism (Increased TH)
Metabolism/weight Weight gain, decreased BMR Weight loss despite increased appetite, increased BMR
Temperature Cold intolerance Heat intolerance, sweating
Cardiovascular Bradycardia, pericardial effusion Tachycardia, AF, wide pulse pressure
GIT Constipation Diarrhoea, increased motility
CNS Lethargy, cognitive slowing, depression Anxiety, irritability, fine tremor
Skin/hair Dry skin, coarse hair, myxoedema Warm moist skin, fine hair
Reflexes Delayed relaxation of DTR Brisk reflexes
TSH (primary) Elevated Suppressed (<0.01)
Free T4 Low High

Hypothyroidism vs Hyperthyroidism

Hypothyroidism vs. Hyperthyroidism: Physiological Basis of Clinical Features

Figure: Hypothyroidism vs. Hyperthyroidism: Physiological Basis of Clinical Features

Four-panel illustration comparing hypothyroidism and hyperthyroidism clinical features mapped to physiology, Graves' disease mechanism with TSH receptor antibodies, and Hashimoto's thyroiditis with lymphocytic destruction.
System Hypothyroidism (Decreased TH) Hyperthyroidism (Increased TH)
Metabolism/weight Weight gain, decreased BMR Weight loss despite increased appetite, increased BMR
Temperature Cold intolerance Heat intolerance, sweating
Cardiovascular Bradycardia, pericardial effusion Tachycardia, AF, wide pulse pressure
GIT Constipation Diarrhoea, increased motility
CNS Lethargy, cognitive slowing, depression Anxiety, irritability, fine tremor
Skin/hair Dry skin, coarse hair, myxoedema Warm moist skin, fine hair
Reflexes Delayed relaxation of DTR Brisk reflexes
TSH (primary) Elevated Suppressed (<0.01)
Free T4 Low High

Hypothyroidism vs Hyperthyroidism

System Hypothyroidism (Decreased TH) Hyperthyroidism (Increased TH)
Metabolism/weight Weight gain, decreased BMR Weight loss despite increased appetite, increased BMR
Temperature Cold intolerance Heat intolerance, sweating
Cardiovascular Bradycardia, pericardial effusion Tachycardia, AF, wide pulse pressure
GIT Constipation Diarrhoea, increased motility
CNS Lethargy, cognitive slowing, depression Anxiety, irritability, fine tremor
Skin/hair Dry skin, coarse hair, myxoedema Warm moist skin, fine hair
Reflexes Delayed relaxation of DTR Brisk reflexes
TSH (primary) Elevated Suppressed (<0.01)
Free T4 Low High

Understanding thyroid physiology lets you predict every clinical feature:

Hypothyroidism vs. Hyperthyroidism: Physiological Basis of Clinical Features

Figure: Hypothyroidism vs. Hyperthyroidism: Physiological Basis of Clinical Features

Four-panel illustration comparing hypothyroidism and hyperthyroidism clinical features mapped to physiology, Graves' disease mechanism with TSH receptor antibodies, and Hashimoto's thyroiditis with lymphocytic destruction.

Hypothyroidism (↓ BMR, ↓ sympathetic tone, ↓ cardiac output):
- Weight gain (↓ BMR), cold intolerance (↓ thermogenesis), constipation (↓ gut motility)
- Bradycardia (↓ β1 receptor upregulation), pericardial effusion (↑ capillary permeability + ↓ lymphatic drainage)
- Dry skin, hair loss (↓ protein synthesis), periorbital/ankle myxoedema (accumulation of glycosaminoglycans)
- Lethargy, cognitive slowing, depression (↓ CNS metabolic rate)
- Delayed relaxation of deep tendon reflexes (classic sign — slowness of muscle relaxation)
- Lab: ↑ TSH, ↓ free T4

Causes: Hashimoto's thyroiditis (#1 worldwide), iodine deficiency (#1 in developing world), post-radioiodine, post-surgical.

Hyperthyroidism (↑ BMR, ↑ sympathetic-like effects — as in Kavya's case):
- Weight loss despite increased appetite, heat intolerance, sweating, diarrhoea
- Tachycardia, atrial fibrillation (especially in elderly), palpitations
- Tremor of outstretched hands, anxiety, emotional lability
- Proximal myopathy (catabolism of muscle), lid lag (Graves' specific: exophthalmos due to retroorbital inflammation)
- Lab: ↓ TSH (often undetectable), ↑ free T4 and T3

Causes of hyperthyroidism: Graves' disease (TSH receptor antibody), toxic multinodular goitre, toxic adenoma.
Treatment options: antithyroids (carbimazole), radioiodine (¹³¹I), thyroidectomy.

SELF-CHECK — : Thyroid & Pituitary

A 45-year-old woman has TSH = 18 mIU/L (high) and free T4 = 0.3 ng/dL (low). She complains of fatigue and weight gain. Which negative feedback loop is disrupted?

A. High T4 is failing to suppress TSH

B. Low T4 is failing to suppress TSH — the pituitary is appropriately increasing TSH

C. The hypothalamus is over-secreting somatostatin

D. ADH feedback to the posterior pituitary is interrupted

Reveal Answer

Answer: B. Low T4 is failing to suppress TSH — the pituitary is appropriately increasing TSH


A patient with Graves' disease undergoes radioiodine (¹³¹I) therapy. Which property of the thyroid gland makes this treatment possible?

A. Thyroglobulin binds radioiodine irreversibly

B. TPO converts radioiodine faster than stable iodine

C. The Na-I symporter actively concentrates iodine in follicular cells

D. Radioiodine is secreted by parafollicular C cells

Reveal Answer

Answer: C. The Na-I symporter actively concentrates iodine in follicular cells

Adrenal Cortex: Zones and Steroids

Adrenal Cortex — Zones, Hormones, and Disorders

Zone Hormone Regulation Main Actions Excess Disorder Deficiency Disorder
Glomerulosa Aldosterone RAAS, K+ Na+ retention, K+ excretion Conn's syndrome (hypertension, hypokalaemia) Addison's (hypotension, hyperkalaemia)
Fasciculata Cortisol CRH → ACTH Gluconeogenesis, anti-inflammatory, stress Cushing's syndrome (moon face, central obesity) Addison's (hypoglycaemia, fatigue)
Reticularis DHEA, androstenedione ACTH Weak androgens; converted to testosterone/oestrogen peripherally Virilisation in females (CAH) Decreased libido (minor in males)

Adrenal Cortex — Zones, Hormones, and Disorders

Adrenal Cortex: Zones and Steroids

Figure: Adrenal Cortex: Zones and Steroids

Four-panel illustration showing adrenal gland zonal anatomy with their steroid products, cortisol regulation and actions, aldosterone regulation via RAAS and its collecting duct effects, and clinical features of Cushing's syndrome versus Addison's disease.
Zone Hormone Regulation Main Actions Excess Disorder Deficiency Disorder
Glomerulosa Aldosterone RAAS, K+ Na+ retention, K+ excretion Conn's syndrome (hypertension, hypokalaemia) Addison's (hypotension, hyperkalaemia)
Fasciculata Cortisol CRH → ACTH Gluconeogenesis, anti-inflammatory, stress Cushing's syndrome (moon face, central obesity) Addison's (hypoglycaemia, fatigue)
Reticularis DHEA, androstenedione ACTH Weak androgens; converted to testosterone/oestrogen peripherally Virilisation in females (CAH) Decreased libido (minor in males)

Adrenal Cortex — Zones, Hormones, and Disorders

Zone Hormone Regulation Main Actions Excess Disorder Deficiency Disorder
Glomerulosa Aldosterone RAAS, K+ Na+ retention, K+ excretion Conn's syndrome (hypertension, hypokalaemia) Addison's (hypotension, hyperkalaemia)
Fasciculata Cortisol CRH → ACTH Gluconeogenesis, anti-inflammatory, stress Cushing's syndrome (moon face, central obesity) Addison's (hypoglycaemia, fatigue)
Reticularis DHEA, androstenedione ACTH Weak androgens; converted to testosterone/oestrogen peripherally Virilisation in females (CAH) Decreased libido (minor in males)

The adrenal cortex has three concentric zones — a useful mnemonic is GFR (which also means Glomerular Filtration Rate — helps you remember it):

Adrenal Cortex: Zones and Steroids

Figure: Adrenal Cortex: Zones and Steroids

Four-panel illustration showing adrenal gland zonal anatomy with their steroid products, cortisol regulation and actions, aldosterone regulation via RAAS and its collecting duct effects, and clinical features of Cushing's syndrome versus Addison's disease.

Glomerulosa → Mineralocorticoids (aldosterone)
Fasciculata → Glucocorticoids (cortisol)
Reticularis → Androgens (DHEA, androstenedione)

All are derived from cholesterol (hence connection to BI lipid metabolism).

Aldosterone (zona glomerulosa):
Regulation: primarily by RAAS (angiotensin II → aldosterone); also by ↑ plasma K⁺ (direct stimulation); weakly by ACTH.
Actions: Na⁺ retention, K⁺ secretion in collecting duct (ENaC channels). Net effect: ↑ blood volume → ↑ BP.
Excess: Conn's syndrome (primary hyperaldosteronism) — hypertension + hypokalaemia. Often from an adrenal adenoma.

Cortisol (zona fasciculata):
Regulation: CRH → ACTH → cortisol. Diurnal rhythm: peaks at 8 AM (awakening), nadir at midnight.
Actions:
- ↑ Gluconeogenesis, ↑ glycogenolysis, ↑ lipolysis → ↑ blood glucose (anti-insulin)
- Anti-inflammatory and immunosuppressive (used pharmacologically as prednisolone/dexamethasone)
- ↑ Protein catabolism (striae, muscle wasting, thin skin in excess)
- Permissive for catecholamine effects on blood vessels
- ↑ Renal free water clearance

Excess: Cushing's syndrome — central obesity, moon face, buffalo hump, hypertension, hyperglycaemia, striae, proximal myopathy, osteoporosis, immunosuppression.
Deficiency: Addison's disease (primary adrenal insufficiency) — fatigue, hypotension, hypoglycaemia, hyponatraemia, hyperkalaemia, hyperpigmentation (↑ ACTH/MSH).

Adrenal medulla:
Adrenaline (80%) and noradrenaline (20%) — synthesised from tyrosine, catecholamines, released in response to acute stress (fight-or-flight).
Actions: ↑ HR, ↑ CO, ↑ blood glucose (glycogenolysis), bronchodilation (β2), redistribution of blood flow (skin/gut vasoconstriction, skeletal muscle vasodilation).
Phaeochromocytoma: catecholamine-secreting tumour → paroxysmal hypertension, sweating, palpitations, headache.

Insulin and Glucagon: Glucose Homeostasis

Insulin vs Glucagon — Opposing Actions

Parameter Insulin (Fed State) Glucagon (Fasted State)
Blood glucose effect Lowers Raises
Glycogen Promotes synthesis (glycogenesis) Promotes breakdown (glycogenolysis)
Gluconeogenesis Inhibits Stimulates
Lipolysis Inhibits Stimulates
Ketogenesis Inhibits Stimulates
Protein Promotes synthesis Promotes catabolism (amino acids for gluconeogenesis)
Potassium Drives K+ into cells (lowers serum K+) No direct effect
Secretion stimulus High glucose, amino acids, incretins Low glucose, amino acids, sympathetic

Insulin vs Glucagon — Opposing Actions

Insulin and Glucagon: Glucose Homeostasis

Figure: Insulin and Glucagon: Glucose Homeostasis

Four-panel illustration showing pancreatic islet cell types, the beta cell insulin secretion mechanism via K-ATP channels and Ca2+ influx, insulin versus glucagon actions in fed and fasted states, and GLUT transporter distribution across tissues.
Parameter Insulin (Fed State) Glucagon (Fasted State)
Blood glucose effect Lowers Raises
Glycogen Promotes synthesis (glycogenesis) Promotes breakdown (glycogenolysis)
Gluconeogenesis Inhibits Stimulates
Lipolysis Inhibits Stimulates
Ketogenesis Inhibits Stimulates
Protein Promotes synthesis Promotes catabolism (amino acids for gluconeogenesis)
Potassium Drives K+ into cells (lowers serum K+) No direct effect
Secretion stimulus High glucose, amino acids, incretins Low glucose, amino acids, sympathetic

Insulin vs Glucagon — Opposing Actions

Parameter Insulin (Fed State) Glucagon (Fasted State)
Blood glucose effect Lowers Raises
Glycogen Promotes synthesis (glycogenesis) Promotes breakdown (glycogenolysis)
Gluconeogenesis Inhibits Stimulates
Lipolysis Inhibits Stimulates
Ketogenesis Inhibits Stimulates
Protein Promotes synthesis Promotes catabolism (amino acids for gluconeogenesis)
Potassium Drives K+ into cells (lowers serum K+) No direct effect
Secretion stimulus High glucose, amino acids, incretins Low glucose, amino acids, sympathetic

Insulin (from β cells of islets of Langerhans) and glucagon (from α cells) are the primary regulators of blood glucose. They have opposing actions and are regulated primarily by blood glucose itself.

Insulin and Glucagon: Glucose Homeostasis

Figure: Insulin and Glucagon: Glucose Homeostasis

Four-panel illustration showing pancreatic islet cell types, the beta cell insulin secretion mechanism via K-ATP channels and Ca2+ influx, insulin versus glucagon actions in fed and fasted states, and GLUT transporter distribution across tissues.

Insulin release:
- Primary stimulus: ↑ blood glucose → glucose enters β cells via GLUT2 → metabolised → ↑ ATP → closes K-ATP channels → depolarisation → Ca²⁺ influx → exocytosis of insulin granules
- Also stimulated by: amino acids, GLP-1 and GIP (incretin hormones from gut), vagal nerve, glucagon
- Inhibited by: hypoglycaemia, somatostatin, sympathetic (α2), fasting

Insulin actions (anabolic — all about storing fuel):
- Glucose: ↑ GLUT4 insertion in muscle and fat → glucose uptake; ↑ glycogen synthesis; ↓ gluconeogenesis
- Protein: ↑ amino acid uptake, ↑ protein synthesis, ↓ proteolysis
- Fat: ↑ lipogenesis, ↓ lipolysis, ↓ ketogenesis
- K⁺: ↑ cellular K⁺ uptake (used clinically to treat hyperkalaemia — insulin + glucose infusion)

Glucagon actions (catabolic — all about mobilising fuel):
- ↑ Glycogenolysis and ↑ gluconeogenesis (liver) → ↑ blood glucose
- ↑ Lipolysis → ↑ fatty acids → ↑ ketogenesis (important in T1DM: no insulin → unchecked glucagon → DKA)
- Glucagon not effective on muscle (muscle lacks glucagon receptors for glycogenolysis)

Insulin:glucagon ratio determines metabolic state:
- High ratio (fed state): anabolic — store fat, build protein, replenish glycogen
- Low ratio (fasted/starved): catabolic — break down glycogen, fat, (eventually) protein